This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression
Science communication brings behavioural changes
To enable company to be future-ready by tapping potential in CDMO space
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
Bourgoin early development hub broadens offerings for oral solid dose formulations
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Acetazolamide is used to treat glaucoma
Subscribe To Our Newsletter & Stay Updated
